Key facts
- Notable investors include CVX Ventures, Exist Federal Ministry of Economics and Energy, HdM Startup Center, L-Bank, M.Tech Accelerator — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Coreway
- ·The full record, as it builds
Funding rounds
No funding rounds for Coreway are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Coreway
Developer of a digital disease management platform designed to improve the quality of life for individuals with chronic inflammatory bowel disease. The company's platform offers data-driven self-monitoring, personalized insights, early relapse detection, and proactive daily support tools, enabling patients with Crohn's disease and ulcerative colitis to manage symptoms effectively and maintain better control over their condition.
- Sector
- Healthcare
- HQ
- Gmund, Austria
- Founded
- 2022
- Employees
- 7
- Website
- core-way.de/
- Ownership
- Privately Held (backing)
Coreway doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Coreway shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Coreway in its N-PORT filings yet. We sweep new filings monthly.